Azenta, Inc.
AZTA Healthcare Medical Instruments & Supplies
Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
Follow AZTA
Azenta, Inc. (AZTA) Altman Z-score
Azenta, Inc.'s Altman Z-score for fiscal 2025 is 3.85, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 3.85 | (2.33) |
| FY2024 | 6.18 | (0.92) |
| FY2023 | 7.10 | 0.17 |
| FY2022 | 6.93 | (2.44) |
| FY2021 | 9.37 | 3.45 |
| FY2020 | 5.92 | 1.81 |
| FY2019 | 4.11 | 0.35 |
| FY2018 | 3.76 | (3.30) |
| FY2017 | 7.07 | 4.25 |
| FY2016 | 2.82 | (0.23) |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.23 | — | 0.27 | |
| Retained earnings / total assets | 0.69 | — | 0.97 | |
| EBIT / total assets | (0.01) | — | −0.04 | |
| Market value of equity / total liabilities | 3.95 | — | 2.37 | |
| Sales / total assets | 0.29 | — | 0.29 | |
| Altman Z-score | Safe zone | 3.85 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 9.11 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 31.4× |
| ATRC AtriCure, Inc. compare | 7.3× |
| LMAT LeMaitre Vascular, Inc. compare | 7.0× |
| STAA STAAR Surgical Company compare | 6.4× |
| WRBY Warby Parker Inc. compare | 4.7× |
| KMTS Kestra Medical Technologies, Ltd. compare | 3.9× |
| AZTA Azenta, Inc. | 3.9× |
| NVST Envista Holdings Corporation compare | 1.6× |
| XRAY DENTSPLY SIRONA Inc. compare | 0.5× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets